Accupro (quinapril) coated tablets 20 mg. №30

$36.00

Manufacturer: Germany

Purpose: Blocks ACE to lower blood pressure, treat hypertension, and heart failure.

Out of stock

SKU: MED56190 Category:

Description

Accupro (quinapril) Coated Tablets 20 mg. №30

Ingredients

Active ingredient: Quinapril 20 mg.
Other ingredients: lactose monohydrate, microcrystalline cellulose, crospovidone, magnesium stearate, hypromellose, polyethylene glycol, titanium dioxide, and more.

Dosage

The recommended dosage: 20 mg once daily. Dosage may be adjusted based on individual response.

Indications

Accupro (quinapril) coated tablets are indicated for the treatment of hypertension and congestive heart failure.

Contraindications

Do not use Accupro (quinapril) coated tablets if: you are allergic to quinapril or any other ACE inhibitor, have a history of angioedema, or are pregnant.

Directions

Take Accupro (quinapril) coated tablets orally with or without food as directed by your doctor. Swallow the tablet whole with a full glass of water.

Scientific Evidence

Studies have shown that quinapril, the active ingredient in Accupro tablets, effectively lowers blood pressure and improves cardiac function in patients with hypertension and heart failure.

Additional Information

It is important to monitor blood pressure regularly while taking Accupro (quinapril) coated tablets to ensure optimal control. Contact your healthcare provider if you experience any side effects or have concerns about the medication.

Pharmacological Effects: Quinapril is an ACE inhibitor that works by blocking the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor. By inhibiting this process, quinapril helps dilate blood vessels, reduce blood pressure, and improve cardiac output.

Clinical Trials: Clinical trials have demonstrated the efficacy of quinapril in reducing cardiovascular events and mortality in patients with heart failure and hypertension. One study published in the New England Journal of Medicine showed a significant reduction in the risk of heart failure-related hospitalizations with quinapril treatment compared to placebo.